Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical studies of arthritis therapy target TNF-alpha and Bcl-2

Nov. 27, 2007

Transient improvement in rheumatoid arthritis activity seen with CRx-139

Nov. 27, 2007

The A3AR as putative target of autoimmune disease therapy

Nov. 26, 2007

Further RAPID study data show efficacy of certolizumab in rheumatoid arthritis

Nov. 26, 2007

Adalimumab lowers uveitis flare rate in ankylosing spondylitis patients

Nov. 26, 2007

Preclinical data from AHA meeting on cardiac ischemia therapies

Nov. 26, 2007

Niacin/laropiprant combined with simvastatin improves dyslipidemia

Nov. 23, 2007

Efficacy similar with naproxcinod and naproxen in osteoarthritis patients

Nov. 23, 2007

MQX-503 reduces the severity of Raynaud's phenomenon in clinical studies

Nov. 23, 2007

TMC-435350 safe in phase I trial in heathy volunteers

Nov. 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...